The effect of proteins soluble in acidic chloroform-methanol (ACMS proteins) on the transcriptase activity of virus ribonucleoproteins (RNPs) in vitro has been studied. Experiments with ACMS membrane (M) proteins from type A and B orthomyxoviruses, as well as from vesicular stomatitis virus, showed that inhibition of the viral RNP transcriptase activity occurred when they interacted with M proteins isolated from viruses of a different serotype, or even of a different family. The presence of ACMS proteins capable of inhibiting the transcriptase activity of orthomyxovirus RNP in vitro was also detected in human blood plasma and among proteins produced by human leukocytes. Determination of the minimum concentration of M protein inhibiting the RNP transcriptase activity, and analysis of the fowl plague virus M protein-RNP complex formed in the in vitro system, showed that the M protein was capable of inhibiting RNP transcriptase activity at a M:RNP ratio of 0.1 to 0.2:1.
INTRODUCTION
Structural proteins of virions of large RNA-containing viruses with a negative genome (orthomyxoviruses, paramyxoviruses, rhabdoviruses) are known to include a membrane (M) protein in large amounts. This protein participates in assembly of the virions, forming an internal membrane closely associated with virus ribonucleoprotein (RNP). According to reports in the literature, the M protein of vesicular stomatitis (VSV) and influenza viruses inhibits the RNP transcriptase activity of a homologous virus in experiments in vitro (Carroll & Wagner, 1979; Zvonarjov & Ghendon, 1980) . The M protein isolated from the virions of negative strand viruses possesses some physical and chemical peculiarities; one of the most important of them is its solubility in chloroformmethanol mixture at acid pH (acidic chloroform-methanol, ACM) (Gregoriades, 1973) . Proteins soluble in ACM (ACMS proteins) have been isolated not only from viruses, but from membrane structures of myelin, mitochondria and bacteria as well (Folch & Less, 1951 ; Gagnon et al., 1971 ; Sanderman & Strominger, 1971 ; Tzagaloff & Kawai, 1972) .
In the present investigations, our aim was to study the effect of M proteins isolated from virions of homologous and heterologous viruses, as well as that of those proteins isolated from other sources which are, like M proteins, soluble in ACM, on the transcriptase activity of virus RNP in vitro.
The results obtained show that inhibition of the transcriptase activity of viral RNPs in vitro occurs upon interaction with the M protein isolated from viruses of a different serotype, or even of a different family. In addition, ACMS proteins capable of inhibiting the transcriptase activity of influenza virus RNP in vitro have been found in human blood plasma and among the proteins produced by human leukocytes.
METHODS

Viruses.
The following viruses were used : fowl plague virus (FPV) Weybridge strain (H7N7; influenza A virus); influenza B virus, B/Japan/73 strain and vesicular stomatitis virus, Indiana serotype. All the viruses were grown in 10-day-old chick embryos, then concentrated and purified on sucrose density gradients.
022-1317/83/0000-5288 $02.00 © 1983 SGM Isolation of M proteins from virions. The method of Gregoriades (1973) was used. Purified virus was resuspended in NT buffer (0.1 M-NaCI, 0-01 i-Tris HCI pH 7-4). Two vol. of neutral chloroform-methanol (2 :l, v/v) were added to the virus. The mixture was vigorously shaken for 5 min and centrifuged at 2000 rev/min for 10 min. Chloroform-methanol (1.8 : 1, v/v) containing 0.04 M-HCI was added to the interphase, vigorously shaken for 5 min and centrifuged at 2000 rev/min for 15 min. The supernatant was decanted, and its volume reduced 3-to 5-fold by vacuum evaporation followed by precipitation of the dissolved protein by the addition of 3 vol. cold ether. The mixture was left on ice for 20 min and then centrifuged at 2500 rev/min for 20 min.
Isolation of ACMS proteins from a lipoprotein fraction of human blood plasma. Lipoprotein fractions were isolated from human blood plasma as described by Scherbakova et al. (1981) . For this purpose, 303 mg NaBr was added per ml plasma to give a final solution density of 1.21 g/ml. Then, 4 ml samples of plasma were placed into centrifuge tubes in a Beckman SW50 rotor, overlaid with 2 ml saline at a final density of 1.21 g/ml, and centrifuged at 40000 rev/min at 20 °C for 24 h. A lipoprotein fraction (a narrow yellow band on top of the gradient) was collected, and the proteins soluble in ACM were isolated as described by Gregoriades (1973) .
Isolation of ACMS proteins from the proteins produced by leukocytes. Human blood leukocytes were kindly provided by Dr T. G. Orlova (Gamaleya Institute of Microbiology and Epidemiology); 5 x l08 leukocytes were incubated in 10 ml of Eagle's medium at 37 °C for 17 h. The cells were removed by centrifugation at 2000 rev/min, and the proteins were precipitated from the supernatant with 3 vol. ethanol. The protein precipitate was suspended in NT buffer, and the fraction soluble in ACM was isolated according to the method of Gregoriades (1973) .
The effect of the ACMS proteins on the in vitro transcriptase activity of vh'ion RNPs. RNP from purified influenza virions was obtained according to Zvonarjov & Ghendon (1980) , and that from VSV virions as described by Carroll & Wagner (1979) . The proteins soluble in ACM were isolated as described above and solubilized in 0-25 Nonidet P40. The composition of the incubation mixture for detection of RNP transcriptase activity in vitro was similar to that described by Zvonarjov & Ghendon (1980) for influenza virus, and to that described by Carroll & Wagner (1979) for VSV, differing only in that the incubation mixture for detection of the transcriptase activity of influenza virus RNP always contained 0.13 mM-GpG, and [3H]UTP ('Isotope', U.S.S.R.) at 10 ktCi/sample (sp. act. 20 Ci/mmol) was added to both incubation mixtures. A 50 lag amount of RNP protein and 80 lag of ACMS proteins were added into the system.
The analysis of the Mprotein-FPV RNP complex. The system used for studying RNP transcriptase activity, containing 250 ~g RNP and 250 vtg M protein in 625 p.1 was incubated at 33 °C for 60 min, layered on to a 15 to 30 glycerol gradient prepared in NT buffer and centrifuged in a MSE Superspeed centrifuge (in the 6 x 38 ml rotor) at 18000 rev/min at 4 °C for 17 h. The virus RNP remains in the gradient under these conditions, while the RNP-M protein complex sediments to the bottom. The pellet was dissolved in a solubilizing buffer (5 M-urea, 1X SDS, 0.1 ~ 2-mercaptoethanol) and analysed by electrophoresis in a 6 to 12~ polyacrylamide gel. Gels, stained with amido black, were subjected to densitometry.
Immunoprecipitation assay. This was carried out in 1 ~ agarose prepared in 0-5 M-sodium phosphate buffer pH 7.5, containing 1 ~ Triton X-100. FPV purified in a sucrose gradient was disrupted in 0.3 % SDS and supplemented with 1 ~ Triton X-100. Rabbit anti-HA serum was obtained by the method of Ginzburg (1975) . Anti-RNP serum was prepared by inoculation of rabbits with FPV obtained and purified as described by Pons et al. (1969) , according to the scheme developed by Ginzburg (1975) . The gamma-globulin fraction was isolated on a DEAEcellulose column (Mikhejeva et al., 1978) . Protein concentration was determined as described by Lowry et al. (1951) . Table 1 presents the results of studies on the effect of M proteins isolated from FPV and influenza B virus on the transcriptase activity of RNP isolated from FPV or influenza B virus. Homologous (i.e. the M protein and RNP were isolated from a virus of the same serotype), and heterologous (i.e. the M protein and RNP were isolated from viruses of different serotypes) inhibitions had no significant quantitative differences and were about 71 to 87~. Control experiments demonstrated the absence of RNase activity in preparations of the M protein isolated from FPV virions (see Table 4 ). Bovine serum albumin (BSA), treated in the same way as virions, was used as a control protein possessing properties differing from those of the M protein, and also as a control for the possible effects of residual amounts of organic solvents (chloroform, methanol, ether) used for isolation of the M protein. The data obtained show that BSA thus treated failed to inhibit the transcriptase activity of FPV RNP. Addition of Nonidet P40 into the system at the same concentration as was used for solubilizing the M protein, also failed to reduce the transcriptase activity of FPV RNP. Table 2 shows the results of studies on the effect of the M protein on RNP transcriptase activity in a homologous (i.e the M protein and RNP were isolated from the same virus), or in a heterologous (i.e the M protein and RNP were isolated from viruses of different families) system. M protein isolated from VSV inhibited the RNP transcriptase activity of FPV and B/Japan influenza virus to nearly the same degree as in th e homologous system containing VSV RNP. Similarly, the M protein isolated from FPV or influenza B virus inhibited the transcriptase activity of VSV RNP to the same degree as that of RNP of homologous strains ( Table 2) .
RESULTS
The effect of M protein on the in vitro transcriptase activity of influenza virus RNP
The effect of the M protein on the in vitro transcriptase activity of RNP of heterologous viruses
The effect of a fraction of the ACMS proteins isolated from blood plasma, and of those produced by leukocytes, on the transcriptase activity of influenza virus RNP
ACMS proteins were isolated not only from the virions of negative strand viruses (M protein), but also from a number of other structures. Bearing in mind that the virus M protein possesses significant lipophilic properties (Gregoriades, 1980) , we attempted to isolate such ACMS proteins from a lipoprotein fraction of human blood plasma and study its effect on the in vitro transcriptase activity of influenza virus RNP. Analysis by polyacrylamide gel electrophoresis revealed two fractions (Fig. 1, curve b) ; the electrophoretic mobility of one of them was somewhat higher, while that of the other fraction was lower than the electrophoretic mobility of the M protein isolated from FPV virions (the tool. wt. of the M protein of orthomyxoviruses is about 25 000). Addition of human blood plasma ACMS proteins to the system containing FPV RNP led to the suppression of UMP incorporation by 71 ~o, i.e. to nearly the same degree as the addition of the M protein isolated from FPV virions (Table 3) . We also looked for a similar protein in human leukocytes. Human blood leukocytes were incubated at 37°C in Eagle's medium; cells were then removed from the medium by centrifugation, and the ACMS protein was isolated according to the method of Gregoriades (1973) . Comparative studies by polyacrylamide gel electrophoresis of this protein and standard proteins of orthornyxoviruses with known molecular weights (Compans et al., 1970) showed uridine-labelled cellular RNA was isolated from CEF culture and diluted with NT buffer to 29 × 103 ct/min/0.1 ml, This amount of RNA was then supplemented with 20 ~tl (50 to 70 ~tg) of ACMS protein solubilized in 0.25~ NP40, or diluted native blood serum, or RNase A. After incubation at 33 °C for 60 rain, samples were treated with 10 ~ trichloroacetic acid. Results are expressed as acid-insoluble ct/min/0-l ml sample. The percentage of labelled cellular RNA rendered acid-soluble is given in parentheses.
~" The experiments were carried out as described in Table 1 and in Methods. Percentage inhibition of the transcriptase activity is given in parentheses.
( Fig. 1 ) that the protein tested had a tool. wt. of about 45000. ACMS proteins, isolated from the proteins produced by leukocytes, inhibited the transcriptase activity of RNP by 82 ~ (Table 3) .
Since blood is known to possess a significant RNase activity, we examined the RNase activity of the proteins soluble in ACM isolated from blood lipoproteins and from the proteins produced by human leukocytes. Control experiments showed that the ACMS proteins isolated from blood plasma, or leukocytes, possessed some RNase activity and rendered 48 ~ (lipopr0teins) and 59 (leukocyte proteins) of the [3H]uridine-labelled cellular RNA acid-soluble (Table 4) . We tried to remove RNase contaminating preparations of the ACMS protein by using a carboxymethylcellulose CM52 column (Palacios et al., 1972) . However, we were unable to use the method for this purpose since the ACMS proteins, the M protein from purified FPV virions in particular, are firmly bound to CM-cellulose, and it proved impossible to remove them by NaC1 gradient concentration. To examine the possible role of RNase activity of preparations of the ACMS proteins isolated from blood leukocytes in the inhibition of transcriptase activity of influenza virus RNP, we carried out experiments on the addition of comparable amounts of RNase into the system containing FPV RNP; the RNases used were human native serum and RNase A (Calbiochem). The results presented in Table 4 show that human native serum diluted 1:1500 rendered 38~ of labelled cellular RNA acid-soluble, while ribonuclease A added to a final concentration of 0-001 lag/0.1 ml, rendered 59~ acid-soluble. Thus, the RNase activity of these preparations was approximately the same as that of the ACMS proteins isolated from blood teukocytes. The data presented in Table 4 also show that both the serum and RNase diluted to the above-mentioned levels had'practically no effect on the transcriptase activity of influenza virus RNP. At the same time, the ACMS proteins decreased this activity by 75 to 78~, i.e. to the same degree as did the M protein, isolated from purified virions of FPV, which possesses no RNase activity.
As the source of in vitro transcriptase activity, we used RNP of FPV, which is known to share common antigenic determinants with RNPs of other influenza A viruses, specifically with those of human influenza viruses. It is also known that antibody to RNP proteins can inhibit the transcriptase activity of this complex in vitro (van Wyke et al., 1981) . Since human blood sera could have contained antibody to human influenza virus RNP, we made an attempt to investigate whether such antibody was present in the ACMS fraction of proteins isolated from human blood plasma lipoproteins. In an immunoprecipitation assay of purified, detergentdisrupted FPV virions with rabbit antiserum to RNP of this virus, a clear line of precipitation was observed which was absent upon interaction with the ACMS proteins from human blood plasma (not shown). These data testify to the fact that these proteins contained no antibody to NP M Fig. 2 . Densitometer tracing of a polyacrylamide gel electrophoretic separation of proteins in the RN P-M protein complex of FPV formed in vitro. Electrophoresis was performed in a 6 to 12 ~ gradient gel, and gels were stained with amido black.
RNP antigens of serotype A. The method used for obtaining the ACMS proteins from blood resulted in preparations free of antiviral antibody, even if it was present in the original blood sample. Thus, it has been found that if the initial blood serum contains virus haemagglutinin antibody giving a clear precipitation line, then the proteins soluble in acidic CM isolated from this preparation have no such activity (not shown).
Determination of the minimum amount of A CMS protein capable of inhibiting the RNP transcriptase activity in vitro
In the above studies of the effect of different proteins on the transcriptase activity of FPV RNP in vitro, as well as in our earlier work (Zvonarjov & Ghendon, 1980) we added 80 ~tg of the tested protein per 50 ~tg of RNP protein. Thus, the concentration ratio was 1-6:1, i.e. nearly that which is characteristic of the content of the M and RNP proteins in the virions of orthomyxoviruses. We decided to study what minimal amounts of the M protein from FPV virions, and of the ACMS protein from the blood plasma, cause detectable inhibition of the virus RNP transcriptase activity. A marked inhibition of the transcriptase activity (40 to 45~) in both types of ACMS proteins was observed even at a ratio of these proteins to RNP proteins of 0-2:1; at a ratio 0-5:1 to 1-0:1 inhibition was 70~o or higher (data not shown).
Composition of the M protein-FPV RNP complex
The above results suggest formation of the M protein-RNP complex in the system used for studying the transcriptase activity. To examine such a possibility, a complex was isolated by gradient centrifugation (see Methods). The composition of its proteins was analysed by gel electrophoresis. The data show (Fig. 2 ) that two proteins (M and NP) were present in the isolated complex at a ratio of 0-1:1 (in other experiments this ratio was 0.08:1 to 0.11:1). It should be emphasized that the M protein was not detected in the initial RNP preparation isolated from FPV virions (not shown).
DISCUSSION
The M protein of negative strand viruses takes part in assembly of virions, forming an internal membrane of the virion. In addition, one can assume that the M protein, associating with the virus RNP in the process of morphogenesis, inhibits the potential transcriptase activity of the complex, and thus the transcriptase of newly formed virions does not function. This assumption is supported by recent results showing that the M protein of VSV, and that of influenza virus, inhibits the transcriptase activity during interaction in vitro with RNP of a homologous virus (Carroll & Wagner, 1979; Zvonarjov & Ghendon, 1980) . Participation of the M protein in virus reproduction suggests its close interaction with virus RNP. Previous reports on the analysis of particles formed by phenotypic mixing of rhabdovirus (VSV) and paramyxovirus (simian virus 5) suggests that virus RNP can interact only with its own (homologous) M protein (McSharry et al., 1971) . However, studies on the effect of the M protein on transcriptase activity in vitro of RNP from VSV have shown the absence of type-specificity (Carroll & Wagner, 1979) , while experiments with influenza virus have indicated the absence of strain-specificity in interactions of the M protein with RNP (Zvonarjov & Ghendon, 1980) .
The results of the present investigations show that the inhibition of transcriptase activity of virus RNPs in vitro by M protein is not specific either with respect to the serotype or to the family of the viruses tested. In fact, the transcriptase activity of influenza A virus (FPV) RNP was inhibited not only by the M protein isolated from influenza B virus, but also by the M protein isolated from VSV (and vice versa).
It should be pointed out that the amount of the ACMS protein isolated from FPV virions (M protein) required to inhibit significantly the in vitro transcriptase activity of FPV RNP is rather small, inhibition being observed even at a ratio of ACMS protein to RNP protein of 0.2:1.
Our experiments have shown that, in the system used for studying the RNP transcriptase activity and containing the RNP and M protein of FPV at a ratio of 1:1, an RNP-M protein complex is formed in which the ratio of M to NP proteins is approximately 0-01:1. This ratio is lower than the one at which we observed inhibition of transcription in vitro (0.2:1). However, one can suppose that formation of the complex does not require all of the M protein added to the system. In addition, it should be taken into consideration that there may be a threshold concentration of M protein in the system, below which the complex cannot be formed. It should be noted that the ratio of M to NP in the complex which we have obtained resembles the one reported by Rees & Dimmock (1981) for RNP isolated from virions of the FPV Rostock strain, using milder conditions of isolation than in our experiments. These data and our results suggest that M protein-RNP complexes can exist under natural conditions as well.
We succeeded in isolating the ACMS proteins from human blood plasma and from proteins produced by human leukocytes; they also appeared to be capable of inhibiting the transcriptase activity of influenza virus RNP in vitro.
Preparation of ACMS proteins isolated from blood plasma, or from the proteins produced by leukocytes, have some RNase activity. However, when human serum or RNase were diluted so that their RNase activity was similar to that of the ACMS proteins and added to the system containing influenza virus RNP, inhibition of the transcriptase activity was not observed. The inhibitory activity of the ACMS proteins isolated from human blood plasma does not depend on the presence of antibody to the proteins forming virus RNP in the preparation. These results suggest that the inhibitory effect of the ACMS proteins on the transcriptase activity is a property of the proteins themselves.
The mechanism of the interaction of ACMS proteins with RNP of negative strand viruses in vitro which leads to RNA synthesis inhibition remains obscure. It is likely that, as a result of such an interaction, the conformation of the proteins found in RNP changes; the proteins consequently lose their ability to take part in the process of transcriptase. On the other hand, one cannot exclude the possibility of interaction of the ACMS proteins with the NP protein; as a consequence, the ribonucleoprotein complex might be unable to act as a template to allow the transcription process.
The ACMS proteins isolated from human blood plasma, as well as from the proteins produced by leukocytes, and capable of inhibiting the in vitro transcriptase activity of influenza virus RNP, appear not to be identical. This is confirmed by differences in their electrophoretic mobilities (Fig. 1) . In all probability, human blood contains several species of ACMS proteins capable of inhibiting the transcriptase activity of virus RNP. One cannot rule out the possibility that the presence of such proteins in blood might be a factor in 'non-specific' protection of an organism against viral infection.
